Why the study?
Dyslipidemia in obesity stems from excess production and impaired clearance of triglyceride-rich lipoproteins postprandially, but the impact of Roux-en-Y gastric bypass surgery on postprandial VLDL kinetics and insulin responsiveness was unclear.
Does Roux-en-Y gastric bypass (RYGB) surgery improve postprandial VLDL kinetics and insulin-mediated regulation in morbidly obese patients without diabetes?
Does Roux-en-Y gastric bypass (RYGB) surgery improve postprandial VLDL kinetics and insulin-mediated regulation in morbidly obese patients without diabetes?
Roux-en-Y gastric bypass in severe obesity significantly reduces hepatic VLDL1 production and improves VLDL2 clearance, correlating with improved insulin sensitivity.
RYGB effects on postprandial VLDL kinetics remain hypothesis-generating in nondiabetic obesity; larger prospective studies needed before clinical adoption.
Dyslipidemia in obesity results from excessive production and impaired clearance of triglyceride-rich (TG-rich) lipoproteins, which are particularly pronounced in the postprandial state. Here, we investigated the impact of Roux-en-Y gastric bypass (RYGB) surgery on postprandial VLDL1 and VLDL2 apoB and TG kinetics and their relationship with insulin-responsiveness indices. Morbidly obese patients without diabetes who were scheduled for RYGB surgery (n = 24) underwent a lipoprotein kinetics study during a mixed-meal test and a hyperinsulinemic-euglycemic clamp study before the surgery and 1 year later. A physiologically based computational model was developed to investigate the impact of RYGB surgery and plasma insulin on postprandial VLDL kinetics. After the surgery, VLDL1 apoB and TG production rates were significantly decreased, whereas VLDL2 apoB and TG production rates remained unchanged. The TG catabolic rate was increased in both VLDL1 and VLDL2 fractions, but only the VLDL2 apoB catabolic rate tended to increase. Furthermore, postsurgery VLDL1 apoB and TG production rates, but not those of VLDL2, were positively correlated with insulin resistance. Insulin-mediated stimulation of peripheral lipoprotein lipolysis was also improved after the surgery. In summary, RYGB resulted in reduced hepatic VLDL1 production that correlated with reduced insulin resistance, elevated VLDL2 clearance, and improved insulin sensitivity in lipoprotein lipolysis pathways.
No takes yet. Share an insight, caveat, or question.
Yildirim et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: